[Flow cytometry]

K Nakahara1

  • 1Department of Clinical Laboratory Medicine, Faculty of Medicine, University of Tokyo.

Rinsho Byori. the Japanese Journal of Clinical Pathology
|June 8, 2001
PubMed

Insights

Flow cytometry is essential for diagnosing blood cancers like leukemia by analyzing cell-surface markers. This method, using monoclonal antibodies, improves diagnostic accuracy and aids in treatment decisions for lymphocytic leukemia.

Area of Science:

  • Hematology
  • Immunology
  • Biotechnology

Context:

  • Flow cytometry is a widely adopted technique for cell-surface marker analysis.
  • It is crucial for diagnosing hematological disorders, especially leukemia.
  • Monoclonal antibodies enhance the reliability of cell-surface marker diagnostics.

Purpose:

  • To highlight the indispensable role of flow cytometry in diagnosing hematological disorders.
  • To explain the utility of immunological classification in lymphocytic leukemias.
  • To discuss quantitative antigen analysis and standardization in flow cytometry.

Summary:

  • Flow cytometry enables precise examination of cell-surface markers, vital for diagnosing conditions like leukemia.
  • Immunological classification of lymphocytic leukemias using this technique correlates with pathophysiology and prognosis.
  • The study explores quantitative antigen analysis and the standardization of flow cytometry.

Impact:

  • Improved diagnostic accuracy for hematological disorders, particularly leukemia.
  • Enhanced understanding of lymphocytic leukemia subtypes, aiding prognosis and treatment.
  • Potential for more detailed and reliable cell-surface antigen analysis through quantitative methods and standardization.